Lecanemab: Zeitenwende in der Alzheimertherapie?

MMW Fortschr Med. 2022 Dec;164(21-22):10. doi: 10.1007/s15006-022-2193-0.

[Article in German]

Author

Thomas Müller¹

Affiliation

¹ Springer Medizin, Neu-Isenburg, Germany.

PMID: 36510046
DOI: 10.1007/s15006-022-2193-0

No abstract available

Publication types

News

MeSH terms

Alzheimer Disease*
Humans